The United States will need to have independent experts review COVID-19 vaccine candidates before approval, the country's top drug regulator said ...
FILE PHOTO: Senate HELP Committee's update on COVID-19 and progress toward safely getting back to work and schoolsREUTERS: The United States will need to have independent experts review COVID-19 vaccine candidates before approval, the country's top drug regulator said on Friday , offering reassurance that his agency would not cut corners in the race to roll out a vaccine.
US Food and Drug Administration Commissioner Stephen Hahn said COVID-19 vaccine candidates will be reviewed according to established legal and regulatory standards for medical products, including by an outside advisory committee."Given the widespread potential use of a COVID-19 vaccine, transparent discussion at FDA's Vaccines and Related Biological Products Advisory Committee will be needed...", Hahn and colleagues wrote in the Journal of the American Medical Association.
The US government's Operation Warp Speed aims to expedite development of a vaccine and therapies to treat the novel coronavirus, and the emphasis on speed has provoked public anxiety about the safety and effectiveness of these vaccines, Hahn and the other officials wrote. "There is a line separating the government's efforts to focus resources and funding to scale vaccine development from FDA's review processes, which are rooted in federal statute and established FDA regulations," they added.
Earlier this week, the country's infectious diseases chief, Anthony Fauci, told Reuters political pressure will not determine when a coronavirus vaccine is approved. At about the same time, US President Donald Trump said it was possible for the country to have a coronavirus vaccine before the Nov. 3 election.More than 159,000 people have died in the United States from COVID-19 and more than 4.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US death toll soars as global COVID-19 cases top 19 millionWASHINGTON: Daily coronavirus deaths in the US surged to a three-month high of over 2,000 on Thursday (Aug 6) and the number of cases passed 19 ...
Read more »
Brazil's Bolsonaro orders US$360 million to be set aside for AstraZeneca COVID-19 vaccineBrazilian President Jair Bolsonaro issued a decree on Thursday that will set aside 1.9 billion reais (US$356 million) in funds to purchase and ...
Read more »
India's Serum Institute to get US$150m from Gates Foundation for COVID-19 vaccineThe Serum Institute of India said it will partner with the Bill & Melinda Gates Foundation and international vaccine alliance GAVI to manufacture ...
Read more »
Human trials of COVID-19 vaccine set to begin in IndonesiaHuman trials on a potential coronavirus vaccine are due to start in Indonesia next week as part of a collaboration between state-owned ...
Read more »
Japan announces deal to purchase AstraZeneca's COVID-19 vaccineJapan has agreed to acquire 120 million doses of AstraZeneca Plc's experimental COVID-19 vaccine if it is successfully developed, the health ...
Read more »
Fauci warns COVID-19 vaccine may be only partially effective, public health measures still neededAn approved coronavirus vaccine could end up being effective only 50-60per cent of the time, meaning public health measures will still be needed ...
Read more »